Key statistics
On Thursday, ABBVIE DRN (ABBV34:SAO) closed at 62.36, -16.80% below its 52-week high of 74.95, set on Nov 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 60.15 |
---|---|
High | 62.52 |
Low | 60.15 |
Bid | 61.15 |
Offer | 63.00 |
Previous close | 60.15 |
Average volume | 1.99k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.52 BRL |
---|---|
Annual div yield (ADY) | 2.44% |
Div ex-date | Oct 14 2024 |
Div pay-date | Nov 22 2024 |
Next div ex-date | Jan 14 2025 |
Next div pay-date | Feb 20 2025 |
Data delayed at least 15 minutes, as of Nov 21 2024 09:44 GMT.
More ▼
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines